Effectiveness of Smoking Cessation Education in Patients at a Community Mental Health Center: A Randomized Controlled Trial

What this Trial Is About

Smoking is a major social and health problem affecting millions worldwide, with tobacco addiction causing significant mortality. People with severe mental illnesses like schizophrenia, bipolar disorder, and major depression have smoking rates three to four times higher than the general population, leading to more health issues and higher healthcare costs. This research evaluates smoking cessation education specifically for patients registered at community mental health centers to address this critical health disparity. The study is a randomized controlled trial comparing two groups: one receiving smoking cessation education and one not receiving this training. The education program involves eight sessions over four weeks, held twice weekly, with each session lasting about 40-45 minutes. The sessions include reviews of previous content, feedback collection, and summaries to support learning. Both groups will be assessed before and after sessions, with follow-ups one month and three months after training to evaluate lasting effects. Participants will be involved in regular evaluations using the Fagerström Test for Nicotine Dependence and a Self-Efficacy Scale at multiple points: before training, immediately after, and at two follow-ups. These assessments will measure changes in nicotine dependence and confidence in quitting smoking. The study aims to provide evidence on the effectiveness of nurse-led smoking cessation education in people with severe mental illness, contributing valuable knowledge to improve tobacco control in this vulnerable group.

Effectiveness of Smoking Cessation Education